Keywords: ActRIIB; activin receptor IIB; IGF-1; insulin-like growth factor; IL-6; interleukin; PDE; phosphodiesterase inhibitors; GDF-8; growth differentiation factor 8; TNF-α; tumor necrosis factor alpha; QCT; quantitative computed tomography; FoxO; forkhead box;